ACIP changes prompt concern as pediatricians prepare for fall vaccine season
Pediatricians are urged to follow 2024 guidelines amid ACIP upheaval, vaccine hesitancy, and access issues as children head back to school.
Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAH
Richard Auchus, MD, PhD, highlights data showing that crinecerfont use in children with CAH can improve metabolic outcomes.
Larazotide safe, could improve MISC symptoms as adjuvant therapy
“While our study is small, its results are powerful and have implications not only for MIS-C, but potentially for long COVID,” said lead author Lael Yonker, MD.
Study: Potty training challenges common, with anxiety and setbacks affecting many families
Many families face common potty training challenges, including anxiety and setbacks, highlighting the need for patience and personalized strategies.
Alopecia areata data: Upadacitinib demonstrates improvements in scalp hair coverage
Achieving the primary endpoint, 44.6% and 54.3% of patients treated with upadacitinib (15 mg and 30 mg) reached 80% or more scalp hair coverage.
FDA grants fast track to rezpegaldesleukin for severe alopecia areata in ages 12 and up
Nektar Therapeutics remains on track to announce top-line phase 2 data in December.
FDA approves pegcetacoplan as first treatment for C3 glomerulopathy or IC-MPGN
Pegcetacoplan (Empaveli; Apellis Pharmaceuticals) is indicated for patients 12 years or older to reduce proteinuria.
WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
Suzanne Hollander, MS, RD, LDN; and Timothy Tramontana, MD, offer thoughts on newly FDA-approved sepiapterin for PKU.
FDA approves sepiapterin to treat phenylketonuria in adult, pediatric patients
“Without treatment, individuals with PKU would have very high blood Phe levels...so that results in neurocognitive deficits and mood disorders," Suzanne Hollander, MS, RD, LDN, said.
FDA approves avatrombopag for pediatric immune thrombocytopenia, including new sprinkle formulation
The FDA has approved avatrombopag and new sprinkle formulation for children ≥1 year with chronic ITP, offering an oral, food-flexible treatment option.
Study: Daily emollient for infants could reduce atopic dermatitis incidence
The study enrolled infants not selected for risk, a population that has been studied few times with regard to emollient intervention.
AAP recommends all healthy children 6 months or older receive influenza vaccine
Of the 253 influenza-related pediatric deaths through June 21, 2025, 42.7% occurred in children without a high-risk medical condition.
New case study, HHS adopts influenza recommendation, and back-to-school vaccination
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
Atopic dermatitis phenotypes and allergic disease development in children
Study links early childhood eczema timing to risk of allergies like food allergy, asthma, and rhinitis, with five distinct disease phenotypes identified.
Lori Handy, MD: Vaccine-only visits can help ease back-to-school gaps
Lori Handy, MD, MSCE, highlights how pediatricians can better prepare families and systems for missed vaccines during the back-to-school rush.
Tyra Bryant-Stephens, MD, talks asthma reminders ahead of school year
Tyra Bryant-Stephens, MD, encourages families to revisit asthma triggers, refill medications, and manage allergies to prevent avoidable complications.
Non-autoimmune diabetes common in African youth with T1D diagnosis
Most youth with type 1 diabetes in sub-Saharan Africa lack autoimmune markers, suggesting a distinct, non-autoimmune form of insulin-deficient diabetes.
HHS to remove thimerosal from all influenza vaccines in the US
This week, HHS Secretary Robert F. Kennedy Jr signed the ACIP's recommendation to remove the mercury-based preservative from all influenza vaccines.
23-month-old female with cough, rhinorrhea, and increased work of breathing
Can you guess the diagnosis?
FDA grants fast track designation to SGT-501 gene therapy for CPVT
Solid Biosciences is planning a phase 1b clinical trial of SGT-501 to treat the catecholaminergic polymorphic ventricular tachycardia heart condition.
Nirsevimab demonstrates high effectiveness against RSV in healthy term infants
Nirsevimab reduced RSV-related illness by up to 98% and lowered hospitalizations and health care use among healthy term infants in a real-world study.
Puzzler poll: Diagnose this 23-month-old with cough and rhinorrhea
Can you diagnose this patient? Take our poll and find out! Then check back for the full case, differential diagnosis, and correct diagnosis.
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
John Browning, MD, highlights the importance of fragrance-free, steroid-free creams in managing atopic dermatitis safely and effectively in children.
New genetic test predicts obesity risk in early childhood
A new polygenic risk score enhances obesity risk prediction from childhood to adulthood, offering new insights for early intervention and prevention strategies.
Breaking down neurodiversity, nicotine ingestions increasing, and more
J&J submits icotrokinra NDA for plaque psoriasis in patients 12 years or older
J&J is seeking the first approval for the investigational targeted oral peptide to treat patients 12 years or older with moderate to severe plaque psoriasis.
Infectious Insights: What clinicians need to know this vaccine season
In this episode of Infectious Insights, our host Tina Tan, MD, is joined by general pediatrician Candice Jones, MD, to discuss an unprecedented vaccine season.
One-third of public schools mandate student mental health screening, but barriers persist
U.S. public schools enhance student mental health support through screenings, yet face challenges in ensuring effective follow-up care and resources.
Lori Handy, MD on importance of vaccine catch-up before the school year
Lori Handy, MD, MSCE, emphasizes the role of school entry as a critical time for ensuring children are caught up on routine vaccinations.
Richard Wong, DO, explains challenges children with asthma face in school
Pediatric pulmonologist Richard Wong, DO, outlines how school environments can complicate asthma management for children across all age groups.
